REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. (Nasdaq: REVB) is a clinical-stage biopharmaceutical company focused on immunology and inflammation, operating in the life sciences and biotechnology sector. On January 29, 2024, the company filed an amended registration statement on Form S-1/A with the Securities and Exchange Commission, accession number 0001213900-24-007475, updating its public disclosures in connection with its registered securities. REVB entered the public markets and remains an active filer tracked within the SPAC-adjacent biotech space on SpacDesk. Investors and analysts looking for complete filing timelines, ownership data, and real-time alerts on REVB and the broader SPAC universe can sign up for full data access at SpacDesk.